T-009

N/A

Report date: 2025/06/11 10:35:22
NME

Base Information

Drug NameT-009
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionSerine/threonine-protein kinase B-raf inhibitorsAnticancer protein kinase inhibitors
TargetsSerine/threonine-protein kinase B-raf
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingapore
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Centre Singapore
China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer Centre SingaporeDuke-Nus Medical School
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A